Condition
Hemorrhoid Bleeding
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting2
Not Yet Recruiting1
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07295886RecruitingPrimary
Topical Nifedipine 0.3% Plus Lidocaine 1.5% for Uncomplicated Hemorrhoidal Disease
NCT07264413Not Yet Recruiting
Bleeding Reduction in Grade II-III Haemorrhoids Through Embolization Treatment
NCT06625138Not ApplicableRecruiting
Trial of Latex Vs Non-latex Hemorrhoid Banding
NCT03060616CompletedPrimary
Validation of Hemorrhoidal Bleeding Score
NCT05089500Not ApplicableUnknown
The Two Treatment Methods Compared the Sclerosing Agent Injection and the Rubber Wrapping
Showing all 5 trials